CongressBuys

Rep. Josh Gottheimer bought Sarepta Therapeutics (SRPT)

Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Mar 6, 2023

Transaction
Bought
Amount
$1K–$15K
Owner
Joint
Traded
Mar 6, 2023
Disclosed
Apr 20, 2023
Days to disclose
45
Asset type
Stock
As filed
Sarepta Therapeutics, Inc.
Industry
Biotechnology · Healthcare

Other trades in this filing

All of Gottheimer's trades →

Recent Congress trades in SRPT

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.